Deployed transcranial electrical stimulation, without compromise.
Fail-safe and intelligent hand-held stimulators designed specifically for deployed use. Deliver only the right dose at the right time, with onboard compliance recording and ElectraRx compatibility.
SNAP Headgear accessories
The only head-gear that is simple to self-apply and guarantees accurate electrode placement. The only pre-saturated snap electrodes for tES in deployed environment.
ElectraRx integrates complete screening and assessments, tDCS dose management, and online digital therapeutics all in one place that can be accessed from anywhere.
34% symptom reduction in Major Depression
tDCS-LTE offers a non-invasive, sedation-free, and seizure-risk-free approach for the treatment of major depression, with virtually no side effects.
1 month of sustained antidepressant response post-stimulation
tDCS-LTE delivers optimized and personalized stimulation. The most effective and tolerated stimulation requires intelligent tDCS-LTE technology.
Clinical-grade intelligent tDCS for pain therapy
50% or more reduction
in Fibromyalgia in 50% of subjects
The clinical trial from Harvard Medical Schools shows dramatic Fibromyalgia pain relief starting in just two weeks, with no significant side-effects.
37% or more reduction in
Migraine with less and shorter attacks
Starting in just four weeks, effectiveness greater than pharmacological drugs with minimal side effects based on clinical trial results.
Safe transcranial Electrical Stimulation requires advanced systems designed for consistency, control and supervision.
Soterix Medical REMOTE Neuromodulation (ARTG Entry: 284637) is the only system with devices, accessories, and software designed for deployed use.
REMOTE Neuromodulation is the only system designed from the ground up to allow translation of clinical tES, including tDCS protocols, to diverse deployed environments, while maintaining medical standards.
Soterix Medical REMOTE is supported by over a dozen clinical trials including the demonstration of tolerability, reproducibility, and compliance[1-13].
Four features for double-blind clinical trials:
True operator blinding
True SUBJECT BLINDING
 Delivering Transcranial Direct Current Stimulation Away From Clinic: Remotely Supervised tDCS. Mil Med. 2020
 Telerehabilitation benefits patients with multiple sclerosis in an urban setting. J Telemed Telecare. 2019
 Long term at-home treatment with transcranial direct current stimulation(tDCS) improves symptoms of cerebellar ataxia: a case report. J Neuroeng Rehabil. 2019
 Introducing the thematic series on transcranial direct current stimulation (tDCS) for motor rehabilitation: on the way to optimal clinical use. J Neuroeng Rehabil. 2019
 Generalizing remotely supervised tDCS: feasibility and benefit in Parkinson's disease. J Neuroeng Rehabil 2018
 Remotely-supervised tDCS for clinical trials: guidelines for technology and protocols. Front Syst Neurosci. 2015